MKT Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$540K Buy
5,175
+19
+0.4% +$1.7K 0.17% 77
2026
Q1
$403K Sell
5,156
-4
-0.1% -$308 0.14% 99
2025
Q4
$415K Buy
5,160
+9
+0.2% +$710 0.14% 97
2025
Q3
$396K Hold
5,151
0.15% 100
2025
Q2
$358K Sell
5,151
-14
-0.3% -$918 0.14% 100
2025
Q1
$330K Buy
5,165
+15
+0.3% +$898 0.15% 95
2024
Q4
$271K Sell
5,150
-90
-2% -$5.05K 0.12% 116
2024
Q3
$326K Sell
5,240
-13
-0.2% -$758 0.15% 101
2024
Q2
$303K Sell
5,253
-134
-2% -$8.38K 0.15% 104
2024
Q1
$383K Sell
5,387
-29
-0.5% -$2.21K 0.21% 85
2023
Q4
$441K Sell
5,416
-60
-1% -$4.27K 0.29% 74
2023
Q3
$382K Buy
5,476
+97
+2% +$6.87K 0.29% 71
2023
Q2
$401K Sell
5,379
-36
-0.7% -$2.56K 0.28% 68
2023
Q1
$421K Sell
5,415
-39
-0.7% -$3.27K 0.31% 66
2022
Q4
$489K Buy
5,454
+13
+0.2% +$1.25K 0.37% 57
2022
Q3
$519K Sell
5,441
-10
-0.2% -$990 0.45% 54
2022
Q2
$516K Buy
5,451
+47
+0.9% +$4.59K 0.4% 56
2022
Q1
$534K Buy
5,404
+188
+4% +$19.8K 0.4% 55
2021
Q4
$547K Buy
+5,216
New +$482K 0.43% 49

Other funds holding CVS

MKT Advisors's CVS Position: Q2 2026 in Review

MKT Advisors increased its CVS Health (CVS) stake by 0.37% in Q2 2026, buying an estimated $1.7K and bringing the position to 5,175 shares worth $540K. The position accounts for 0.17% of the portfolio, ranked #77.

MKT Advisors first reported a position in CVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $547K in Q4 2021. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • MKT Advisors held 5,175 shares of CVS Health worth $540K as of Q2 2026.
  • MKT Advisors bought 19 CVS Health shares in Q2 2026, an estimated $1.7K.
  • CVS Health made up 0.17% of MKT Advisors's portfolio in Q2 2026, its #77 holding.
  • MKT Advisors first reported a position in CVS Health in Q4 2021 and has held it in 19 quarters since.
  • MKT Advisors's CVS Health position peaked at $547K in Q4 2021.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on MKT Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.